3rd Quarter - Report
IPOLICY SOLUTIONS for ASSOCIATION FOR MOLECULAR PATHOLOGY
Firm
Income
$45,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medical/Disease Research/Clinical Labs MED
No bill #: Verified Innovative Testing in American Laboratories Act H.R.2369 - VALID Act of 2023 FDA Proposed Rulemaking on LDTs
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN ANDERSON BROOKS | — |
| JENNIFER RACHEL LEIB | Fellow, Senate Committee on Health, Education, Labor, and Pensions |
| LINDSEY TRISCHLER | — |
Health Issues HCR
No bill #: Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization Workforce shortages National Biodefense Science Board Recommendations
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN ANDERSON BROOKS | — |
| JENNIFER RACHEL LEIB | Fellow, Senate Health, Education, Labor and Pensions |
| LINDSEY TRISCHLER | — |
Copyright/Patent/Trademark CPT
S.2140: Patent Eligibility Restoration Act of 2023
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN ANDERSON BROOKS | — |
| JENNIFER RACHEL LEIB | Fellow, Senate Committee on Health, Education, Labor and Pensions |
| LINDSEY TRISCHLER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.